During the past decade, UN Bratislava Nemocnica Ruzinov; Neurologicka klinika conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika" in a lesser frequency.

Most popular intervention types in "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UN Bratislava Nemocnica Ruzinov; Neurologicka klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UN Bratislava Nemocnica Ruzinov; Neurologicka klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".